Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach C Glorieux, PB Calderon Biological chemistry 398 (10), 1095-1108, 2017 | 637 | 2017 |
Gut microbiota-derived propionate reduces cancer cell proliferation in the liver LB Bindels, P Porporato, EM Dewulf, J Verrax, AM Neyrinck, JC Martin, ... British journal of cancer 107 (8), 1337-1344, 2012 | 317 | 2012 |
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects J Verrax, PB Calderon Free Radical Biology and Medicine 47 (1), 32-40, 2009 | 298 | 2009 |
Regulation of catalase expression in healthy and cancerous cells C Glorieux, M Zamocky, JM Sandoval, J Verrax, PB Calderon Free Radical Biology and Medicine 87, 84-97, 2015 | 288 | 2015 |
Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model LB Bindels, R Beck, O Schakman, JC Martin, F De Backer, FM Sohet, ... PloS one 7 (6), e37971, 2012 | 288 | 2012 |
Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy C Glorieux, N Dejeans, B Sid, R Beck, PB Calderon, J Verrax Biochemical pharmacology 82 (10), 1384-1390, 2011 | 191 | 2011 |
Free radicals and oxidation phenomena in biological systems MB Roberfroid, P Buc Calderon (No Title), 1995 | 187 | 1995 |
Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content S Poncin, AC Gérard, M Boucquey, M Senou, PB Calderon, B Knoops, ... Endocrinology 149 (1), 424-433, 2008 | 159 | 2008 |
Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease B Sid, J Verrax, PB Calderon Biochemical pharmacology 86 (2), 200-209, 2013 | 151 | 2013 |
Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents J Benites, JA Valderrama, K Bettega, RC Pedrosa, PB Calderon, J Verrax European journal of medicinal chemistry 45 (12), 6052-6057, 2010 | 138 | 2010 |
The controversial place of vitamin C in cancer treatment J Verrax, PB Calderon biochemical pharmacology 76 (12), 1644-1652, 2008 | 137 | 2008 |
Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors C Diepart, O Karroum, J Magat, O Feron, J Verrax, PB Calderon, ... Cancer research 72 (2), 482-490, 2012 | 136 | 2012 |
Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death J Verrax, J Cadrobbi, C Marques, H Taper, Y Habraken, J Piette, ... Apoptosis 9, 223-233, 2004 | 134 | 2004 |
Comparison of methods for measuring oxygen consumption in tumor cells in vitro C Diepart, J Verrax, PB Calderon, O Feron, BF Jordan, B Gallez Analytical biochemistry 396 (2), 250-256, 2010 | 130 | 2010 |
Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies NM Delzenne, PB Calderon, HS Taper, MB Roberfroid Toxicology letters 61 (2-3), 291-304, 1992 | 124 | 1992 |
Role of oxidative stress in the pathogenesis of alcohol-induced liver disease B Sid, J Verrax, PB Calderon Free radical research 47 (11), 894-904, 2013 | 121 | 2013 |
Autoschizis: a novel cell death JM Jamison, J Gilloteaux, HS Taper, PB Calderon, JL Summers Biochemical pharmacology 63 (10), 1773-1783, 2002 | 118 | 2002 |
The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly V Wauthier, RK Verbeeck, P Buc Calderon Current medicinal chemistry 14 (7), 745-757, 2007 | 114 | 2007 |
Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study J Verrax, M Delvaux, N Beghein, H Taper, B Gallez, P Buc Calderon Free radical research 39 (6), 649-657, 2005 | 111 | 2005 |
Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence N Dejeans, C Glorieux, S Guenin, R Beck, B Sid, R Rousseau, B Bisig, ... Free Radical Biology and Medicine 52 (6), 993-1002, 2012 | 109 | 2012 |